Pacira Pharmaceuticals shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Pacira Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Pacira Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Pacira Pharmaceuticals by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.4M | 367k | 25.77 |
| 2025-06-30 | $9.2M | 386k | 23.90 |
| 2025-03-31 | $9.6M | 386k | 24.85 |
| 2024-12-31 | $7.5M | 396k | 18.84 |
| 2024-09-30 | $5.3M | 355k | 15.05 |
| 2024-06-30 | $11M | 400k | 28.61 |
| 2024-03-31 | $12M | 398k | 29.22 |
| 2023-12-31 | $14M | 425k | 33.74 |
| 2023-09-30 | $14M | 454k | 30.68 |
| 2023-06-30 | $19M | 471k | 40.07 |
| 2023-03-31 | $20M | 483k | 40.81 |
| 2022-12-31 | $18M | 468k | 38.61 |
| 2022-09-30 | $26M | 484k | 53.54 |
| 2022-06-30 | $28M | 475k | 58.30 |
| 2022-03-31 | $39M | 513k | 76.32 |
| 2021-12-31 | $30M | 497k | 60.00 |
| 2021-09-30 | $27M | 478k | 56.00 |
| 2021-06-30 | $29M | 473k | 60.68 |
| 2021-03-31 | $34M | 483k | 70.09 |
| 2020-12-31 | $29M | 486k | 59.84 |
| 2020-09-30 | $31M | 512k | 60.12 |
| 2020-06-30 | $27M | 524k | 51.92 |
| 2020-03-31 | $17M | 491k | 33.53 |
| 2019-12-31 | $23M | 499k | 45.30 |
| 2019-09-30 | $19M | 493k | 38.07 |
| 2019-06-30 | $9.3M | 213k | 43.49 |
| 2019-03-31 | $8.3M | 219k | 38.06 |
| 2018-12-31 | $9.1M | 210k | 43.03 |
| 2018-09-30 | $11M | 222k | 49.15 |
| 2018-06-30 | $7.1M | 222k | 32.05 |
| 2018-03-31 | $7.0M | 226k | 31.15 |
| 2017-12-31 | $10M | 223k | 45.66 |
| 2017-06-30 | $10M | 218k | 47.71 |
| 2017-03-31 | $9.4M | 206k | 45.61 |
| 2016-12-31 | $6.4M | 198k | 32.30 |
| 2016-09-30 | $6.5M | 190k | 34.22 |
| 2016-06-30 | $6.2M | 183k | 33.73 |